Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation

New-Onset Diabetes After Renal Transplantation

(2016) Pablo F. Mora   JOURNAL OF INVESTIGATIVE MEDICINE

Fixed- or Controlled-Dose Mycophenolate Mofetil with Standard- or Reduced-Dose Calcineurin Inhibitors: The Opticept Trial

(2009) R. S. Gaston et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony study

(2009) Ulrich Frei et al.   CLINICAL TRANSPLANTATION

Multicenter, Randomized Study of the Use of Everolimus With Tacrolimus After Renal Transplantation Demonstrates its Effectiveness

(2009) Laurence Chan et al.   TRANSPLANTATION

Mycophenolate Mofetil Decreases Acute Rejection and may Improve Graft Survival in Renal Transplant Recipients When Compared with Azathioprine: A Systematic Review

(2009) Simon R. Knight et al.   TRANSPLANTATION

Mycophenolate mofetil dosage modifications following gastrointestinal complications in renal transplant patients

(2009) Moro O Salifu et al.   Expert Review of Pharmacoeconomics & Outcomes Research

New-Onset Diabetes Mellitus After Kidney Transplantation: The Role of Immunosuppression

(2008) M. Veroux et al.   TRANSPLANTATION PROCEEDINGS

Reduced Risk of Cytomegalovirus Infection in Solid Organ Transplant Recipients Treated With Sirolimus: A Pooled Analysis of Clinical Trials

(2008) L. Demopoulos et al.   TRANSPLANTATION PROCEEDINGS